Knowing Prostate Cancer Before it Hits You: How This Affects Future Healthcare

As reported in News Medical by Dr. Ananya Mandal, with a study done by cancer research centers, both in the US and in Sweden, it has been found that single letter mutations, five of them to be exact, are inherited genetic mutations of prostate cancer. When there is really no way of telling today if prostate cancer in a particular individual is indolent or something that is aggressive, this study will start to open up a whole new world on how prostate cancer is detected and treated. In the studies performed, the five single letter mutations have been isolated. Seeing prostate cancer patients with more than three single letter mutations, it can be determined who has the higher risk of dying from the disease.

Essentially what the study teams are looking for are biomarkers that can be used to distinguish prostate cancer patient if they’re suffering from aggressive tumor or indolent ones. Through the study, it has already been learned that inherited genetic variants have a big part in prostate cancer as well as in mortality. With the identification of biomarkers, it’s going to be possible for health care providers to make an assessment of how aggressive a tumor will be. With things like high Gleason score, men who are at a higher risk of mortality from prostate cancer will be identified.

There’s no doubt that there’s still a lot of room for improvement for the treatment method of prostate cancer. Even if we’re not entirely sure about the aggressiveness of a tumor, there is no choice for the type of treatment that can be done. Through studies made by the Fred Hutchinson Cancer Research Center as well as a counterpart study performed in Sweden, there’s a great potential for prostate cancer detection and treatments to be improved. With studies being expanded to males from other races, prostate cancer can be combated more efficiently.

When these studies have been clinically substantiated with finality, expect this to find its way as part of health insurance benefits. Having the right health insurance plan that covers this screening procedure will put you on a better position to get to know if you are inclined to acquire prostate cancer – similar to what mammogram can on women.

This post was brought to you by Mclain Insurance Group. For more information on Medicare insurance and tips for saving money on your next plan, be sure to check out our site or contact one of our friendly agents at 817-737-0200. We can help you decide on a plan that suits your needs. We’ll help keep insurance costs low by comparing quotes from the state’s top plans. Our insurance quotes are free and so is our service, so you have nothing to lose. Why not get started today and sign up for your free quote online? We’ve helped many individuals find quality Texas Medicare insurance and can do the same for you!